Oclacitinib: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|An article about the medication Oclacitinib}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002547 | |||
| image = Oclacitinib.svg | |||
| image_size = 200px | |||
| image_alt = Chemical structure of Oclacitinib | |||
}} | |||
'''Oclacitinib''' is a medication used in veterinary medicine primarily for the treatment of [[allergic dermatitis]] and [[pruritus]] in dogs. It is a selective [[Janus kinase]] (JAK) inhibitor, which helps to reduce inflammation and itchiness by interfering with the signaling pathways that lead to these symptoms. | |||
Oclacitinib | |||
== | ==Mechanism of Action== | ||
Oclacitinib | Oclacitinib works by inhibiting the activity of [[Janus kinase]] enzymes, specifically JAK1 and JAK3. These enzymes are involved in the signaling pathways of various [[cytokines]] that play a role in the inflammatory and pruritic processes. By blocking these pathways, oclacitinib reduces the production of inflammatory mediators and alleviates symptoms associated with allergic reactions. | ||
== | ==Uses== | ||
Oclacitinib is primarily used to manage [[allergic dermatitis]] and [[pruritus]] in dogs. It is effective in reducing itching and inflammation associated with various allergic conditions, including [[atopic dermatitis]]. | |||
== | ==Administration== | ||
Oclacitinib is administered orally, and the dosage is typically based on the weight of the dog. It is important to follow the veterinarian's prescription to ensure the effectiveness and safety of the treatment. | |||
== | ==Side Effects== | ||
Common side effects of oclacitinib may include [[vomiting]], [[diarrhea]], and [[anorexia]]. In some cases, dogs may experience more serious side effects such as [[immunosuppression]], which can increase the risk of infections. | |||
==Precautions== | |||
Oclacitinib should be used with caution in dogs with a history of [[neoplasia]] or [[immunosuppression]]. It is not recommended for use in dogs less than 12 months of age or in breeding, pregnant, or lactating dogs. | |||
==Related pages== | |||
* [[Allergic dermatitis]] | * [[Allergic dermatitis]] | ||
* [[Pruritus]] | * [[Pruritus]] | ||
* [[ | * [[Janus kinase]] | ||
* [[Cytokine]] | |||
[[Category:Veterinary drugs]] | [[Category:Veterinary drugs]] | ||
[[Category:Janus kinase inhibitors]] | [[Category:Janus kinase inhibitors]] | ||
Revision as of 03:55, 13 February 2025
An article about the medication Oclacitinib
| Oclacitinib | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Oclacitinib is a medication used in veterinary medicine primarily for the treatment of allergic dermatitis and pruritus in dogs. It is a selective Janus kinase (JAK) inhibitor, which helps to reduce inflammation and itchiness by interfering with the signaling pathways that lead to these symptoms.
Mechanism of Action
Oclacitinib works by inhibiting the activity of Janus kinase enzymes, specifically JAK1 and JAK3. These enzymes are involved in the signaling pathways of various cytokines that play a role in the inflammatory and pruritic processes. By blocking these pathways, oclacitinib reduces the production of inflammatory mediators and alleviates symptoms associated with allergic reactions.
Uses
Oclacitinib is primarily used to manage allergic dermatitis and pruritus in dogs. It is effective in reducing itching and inflammation associated with various allergic conditions, including atopic dermatitis.
Administration
Oclacitinib is administered orally, and the dosage is typically based on the weight of the dog. It is important to follow the veterinarian's prescription to ensure the effectiveness and safety of the treatment.
Side Effects
Common side effects of oclacitinib may include vomiting, diarrhea, and anorexia. In some cases, dogs may experience more serious side effects such as immunosuppression, which can increase the risk of infections.
Precautions
Oclacitinib should be used with caution in dogs with a history of neoplasia or immunosuppression. It is not recommended for use in dogs less than 12 months of age or in breeding, pregnant, or lactating dogs.
